Haleon Group - HLN Quarterly Revenue Growth

Official company branding of haleon.com (HLN)

Over-the-counter segment leader Haleon plc (HLN) attracts industry specialists with the stability of the European market, yet the quarterly revenue growth rate illustrated by this chart via GURU.Markets demonstrates volatility, where the current metric equals 15.40. Risks are mitigated by outsourcing distribution to contract partners and the strong pricing power of its brands, which allows the company to increase product costs without losing consumer loyalty.

HLN Haleon Group Quarterly Revenue Growth Rate (04/28/2023 - 11/20/2026)

Analytical breakdowns for Haleon PLC (HLN)

- current quotes and average value forecast:
- cash balance and cash flow data:
Summary company analysis:HLN - Haleon plc
Flagship merchandise of Haleon

To minimize fundamental risks, investors opt for assets with stable capital inflows. This metric measures the percentage change in quarterly revenue compared to the same period last year, revealing the pace of business scaling. For Haleon plc (HLN), with its defensive portfolio of Sensodyne and Voltaren brands, this growth confirms resilience against generic expansion. By analyzing the current level of quarterly sales growth, one can timely identify the overheating phase of the company's valuation.

Competitor analysis for Haleon plc

Kenvue Inc - Quarterly Revenue Growth|Quarterly Revenue Growth Rate veronapharma.com|Jyong Bio (MENS) - Revenue Growth QoQ|Revenue Change vs Previous Quarter Ligand LGND|AMRX (amneal.com) - Quarterly Revenue Growth|PRGO: Quarterly Revenue Increase|Quarterly Sales Growth ALVO (Alvotech Corp)|Quarterly Sales Growth Rate Liquidia Corporation|Quarterly Revenue Growth GLPG (glpg.com)|Quarterly Revenue Increase ANIP|MNKD - Revenue Growth QoQ|Amphastar - Sales Change QoQ|PCRX: Quarterly Revenue Growth|ars-pharma.com - Quarterly Revenue Increase|TBPH (Theravance Biopharma Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)